Please assess the completion status of the following clinical trial:

Trial Title: Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient with genetic pathology of the ocular surface~* Age ≥ 7 years~Exclusion Criteria:~* Agonal glaucoma~* low vision mostly related to retinal pathology~* Pregnant or breast-feeding patient

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).